EAQ-40855-64266
3 vaccinations
1 coded response
9 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 007 / PR
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-21
Registered in v-safe
- 2021-01-01
-
2021-01-04
Dose 2 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-25
- 2021-02-03
- 2021-02-15
- 2021-04-05
- 2021-07-05
-
2021-09-09
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-01-04
-
2022-03-12
Survey response — 6 months, dose 3MedDRA: Chills, Diarrhoea, Headache — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Dolor de cabeza en el cuerpo escalofrÃo, diarreasMedDRA releases: 2024-11 · check-in free text available
-
2022-03-12
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-15
- 2022-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-04 | Pfizer-BioNTech | |
| 3 | 2021-09-09 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 6 months, dose 3
Symptoms: Dolor de cabeza en el cuerpo escalofrÃo, diarreas
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release